Drug · DIN 02349124
EFFIENT
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 10, 2020; first marketed May 17, 2010.
- Drug Identification Number (DIN)
- 02349124
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Prasugrel B01AC22
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PRASUGREL (PRASUGREL HYDROCHLORIDE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 16, 2010: NOC 11252New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “effient”. A notice may cover another product or only some lots: read it to see what it covers.
- EFFIENT (prasugrel hydrochloride) - Association with Increased Risk of Bleeding in Patients Treated in Hospital for Certain Types of Heart Attacks - For Health ProfessionalsJanuary 17, 2014 · Drugs · Product safety
- EFFIENT (prasugrel hydrochloride) - Association with Increased Risk of Bleeding in Patients Treated in Hospital for Certain Types of Heart Attacks - For the PublicJanuary 17, 2014 · Drugs · Product safety